Proneurogen
UEI: CC75K29RDV48
• CAGE: 71UE6
Overview
Awardee Type
Parent
Federal Capability Statement
ProNeurogen is clinical stage biopharmaceutical company developing novel peptide based neuroprotective therapeutics. These peptides are targeted towards the treatment and prevention of surgical, disease and injury induced cognitive impairment.
Keywords
pharmaceuticals
neuropeptides
research
cognition
Website
Headquarters
Tucson, AZ
United States
United States
Most Recent Award
Sept. 22, 2026
Calculating
Proneurogen is a federal grant recipient (UEI CC75K29RDV48; CAGE 71UE6). It is headquartered in Tucson, AZ. Its primary registered NAICS is 541714: Research and Development in Biotechnology (except Nanobiotechnology). The corporation was founded in August 2013 and federally registered in July 2026.
Federal Award Analysis
Proneurogen federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
PRONEUROGEN INC
UEI
CC75K29RDV48
CAGE Code
71UE6
SBA Certifications
None
Self Certifications
Woman Owned Business
Woman Owned Small Business
Woman Owned Small Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Aug. 1, 2013
Initial Registration
July 15, 2026
Last Registration
July 17, 2026
Registration Activation
July 17, 2026
Registration Expiration
July 15, 2027
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
AZ
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
Yes